Allergan, Inc.-Strategy, SWOT and Corporate Finance Report

Allergan, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Allergan, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Allergan, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Allergan, Inc. including a breakdown and examination of key business segments

Intelligence on Allergan, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Allergan, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Allergan, Inc. and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Allergan, Inc. as a prospective partner, vendor or supplier

Support sales activities by understanding your customers’ businesses better

Stay up to date on Allergan, Inc.’s business structure, strategy and prospects

Key Highlights

Allergan (or ‘the company’) is engaged in the discovery, development and commercialization of products addressing ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological and other specialty markets. The company operates primarily in the US, Europe, Asia Pacific and Latin America. The company is headquartered in Irvine, California, and employed approximately 11,400 people as of December 31, 2013.